Your Messages Inbox
Your Article Summary
See Latest ArticlesAmgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp Therapy in CKD Patients With Type-2 Diabetes
Amgen, 08/26/09
Amgen announced that in a large, randomized, double–blind, placebo–controlled, Phase 3 study of patients with chronic kidney disease, anemia and type–2 diabetes, treatment of anemia with Aranesp to a hemoglobin target of 13 g/dL had no statistically significant effect on either of two primary endpoints compared with placebo treatment. The two primary endpoints were a composite of time to all–cause mortality or cardiovascular morbidity and a composite of time to all–cause mortality or chronic renal replacement therapy.
Related Articles
Prevention of Type 2 Diabetes: Risk Status, Clinic, and Community
Journal of General Internal Medicine, 11/09/09
Relevance Score: 96%
Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 10/19/09
Relevance Score: 95%
Cigarette smoking is an independent risk factor for type 2 diabetes: a four-year community-based prospective study
Clinical Endocrinology, 10/16/09
Relevance Score: 94%
Periodontal Disease – The Overlooked Diabetes Complication
Nephrology Nursing Journal, 10/07/09
Relevance Score: 94%
Testing for monogenic diabetes among children and adolescents with antibody-negative clinically defined Type 1 diabetes
Diabetic Medicine, 10/05/09
Relevance Score: 94%
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial
Archives of Drug Information, 12/08/09
Autologous blood therapy for common cold—A randomized, double-blind, placebo-controlled trial
Complementary Therapies in Medicine, 12/08/09
Reduction of biofilm formation with trisodium citrate in haemodialysis catheters: a randomized controlled trial
Nephrology Dialysis Transplantation, 12/08/09
Article Search
Sponsor